Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development.
about
Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Assessment of pazopanib-relate ...... factors for their development.
@en
Assessment of pazopanib-relate ...... factors for their development.
@nl
type
label
Assessment of pazopanib-relate ...... factors for their development.
@en
Assessment of pazopanib-relate ...... factors for their development.
@nl
prefLabel
Assessment of pazopanib-relate ...... factors for their development.
@en
Assessment of pazopanib-relate ...... factors for their development.
@nl
P2860
P1433
P1476
Assessment of pazopanib-relate ...... factors for their development
@en
P2093
Daniel Pinkhas
P2860
P2888
P356
10.1186/S40959-017-0024-8
P577
2017-06-30T00:00:00Z
P6179
1090323637